Venture Capital
AI Venture Capital — How Capital Moves
Funds, accelerators, and funding rounds — $150B flowed into AI startups in 2025. Who's investing, who's raising, and how the returns actually look.
22 articles
OpenAI Is Now Worth $852 Billion — and Chasing a $1 Trillion IPO While Losing $38 Billion a Year
Is the AI Boom a Bubble? The 2026 Numbers That Should Scare You — and the Ones That Say 'Not Yet'
VCWho's Really Paying for the AI Boom? Not Silicon Valley — It's $2.5 Trillion in Gulf Oil Money
Abu Dhabi's MGX, Saudi's PIF, Qatar's QIA and Singapore's GIC are now the biggest backers of OpenAI, Anthropic, and xAI. Gulf funds have committed ~$2.5T to US tech. Here's who actually controls the AI boom — and what it means for your money.
Read Article →
VCMusk's $1.77 Trillion SpaceX IPO Is Secretly the Biggest AI Bet of 2026 — Here's What Nobody's Telling You
SpaceX goes public June 12 at a $1.77 trillion valuation — the largest IPO in history. Everyone calls it a rocket company. But 61% of its capex now goes to AI, it swallowed xAI and Grok, and it's building data centers in orbit. Here's the AI story hiding inside the hype.
Read Article →VC$3 Trillion Goes Public: Inside the SpaceX, Anthropic, and OpenAI IPO Race — and How Not to Get Burned
Anthropic just filed for IPO at a $965B valuation, SpaceX starts its roadshow June 4 targeting ~$1.8T, and OpenAI eyes September. Over $3 trillion is coming to public markets in months. Here's what's really happening — and the lockup traps you need to understand before you buy a single share.
Read Article →
VCAnthropic Closing $30B at $900B Valuation: The Frontier Lab That Just Leapfrogged OpenAI
Anthropic is closing its second $30B round of 2026 — this one at $900B post-money, surpassing OpenAI's $852B. Q2 revenue lands at $10.9B with the first $559M operating profit ever from a frontier lab. The race for the most valuable private AI company just flipped.
Read Article →
VCIsomorphic Labs' $2.1B Round: The VC Bet on AI Drug Discovery
Isomorphic Labs' $2.1 billion Series B shows how AI drug discovery is moving from research prestige into capital-heavy company building, pharma partnerships, and clinical risk.
Read Article →VCElevenLabs' $500M ARR Signal: Why AI Growth Rounds Are Starting to Look Like Public Markets
ElevenLabs crossing $500M ARR while expanding its Series D shows how late-stage AI investing is changing: institutional capital, strategic customers, tenders, and infrastructure-style valuations.
Read Article →
VCAI Roll-Up Strategy in 2026: Buy Cash Flow, Upgrade Ops, Compound Value
How investors and operators use AI-enabled roll-ups to improve margins, operational leverage, and exit quality.
Read Article →
VCAI Series A in 2026: What Investors Ask in Partner Meetings
A practical Series A guide for AI founders: the metrics VCs scrutinize, what changes late in the process, and how to prep your data room.
Read Article →
VCAI Startup Due Diligence in 2026: What Breaks Deals (and How to Prepare)
A founder-focused diligence guide covering technical, commercial, legal, and data-risk checks that commonly derail AI deals.
Read Article →
VCAI Startup Term Sheet Guide (2026): What Founders Must Negotiate First
A plain-English term sheet guide for AI founders: valuation, liquidation, anti-dilution, board control, and negotiation priorities.
Read Article →
VCBeyond VC for AI Startups (2026): Venture Debt, RBF, and Strategic Capital
VC is not the only funding path. A practical guide to venture debt, revenue-based financing, grants, and strategic partnerships for AI founders.
Read Article →
VCBest AI Startup Accelerators: Which Program Gets You Funded Fastest
Y Combinator, Techstars, and NVIDIA Inception compared by funding speed, dilution tradeoffs, and practical founder outcomes.
Read Article →
VCAngel Investing in AI Startups: How to Deploy $25K-$100K for 10-50x Returns
A practical angel investing guide for AI startups focused on portfolio logic, deal quality, and disciplined deployment.
Read Article →
VCAI Exits 2025: The Biggest Acquisitions and What They Mean for Investors
Wiz $32B, Base44 $80M, and more. The biggest AI exits of 2025, who profited, and what patterns predict the next big exits.
Read Article →
VCHow to Raise a Seed Round for Your AI Startup: The $3-8M Playbook
Step-by-step guide to raising $3-8M seed round for AI startups. What investors want, how to pitch, timeline, and common mistakes.
Read Article →
VCImpact Investing in AI: The $28B Market Where Doing Good Pays Well
ESG AI funds, climate AI ($7.2B invested), SDG-aligned startups. Impact investing in AI delivers returns AND social value.
Read Article →
VCTop 15 VC Funds Investing in AI: Who Writes the Biggest Checks
a16z, Sequoia, Lightspeed — the 15 most active AI investors. Portfolio companies, check sizes, and what they look for.
Read Article →
VCAI Companies Going Public in 2026: SPACs, Direct Listings, and the IPO Pipeline
Which AI companies are preparing for IPO in 2026, what routes they are choosing, and how investors can position for the next wave of AI public offerings.
Read Article →
VCAI Startup Valuations 2025-2026: How VCs Price AI Companies and What Multiples to Expect
Revenue multiples, benchmarks, and valuation drivers for AI startups. How VCs decide if your AI company is worth $50M or $5B.
Read Article →
VCAI Venture Debt: How Startups Raise $5M-$50M Without Giving Up Equity
Complete guide to venture debt for AI companies. Who offers it, typical terms, when it makes sense, and how AI startups use debt to extend runway without dilution.
Read Article →